Anterix (ATEX) Cost of Revenue (2013 - 2021)

Anterix (ATEX) has reported Cost of Revenue for 9 consecutive years, with $5000.0 the latest figure, recorded in Q4 2021.

• For the quarter ending Q4 2021, Cost of Revenue fell 99.08% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2023 stood at $5000.0 (down 99.09% YoY), and the FY2022 full-year result was $5000.0, down 99.69% from the prior year.
• Cost of Revenue retreated to $5000.0 in Q4 2021 per ATEX's latest filing, from $543000.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.3 million in Q1 2018 and bottomed at $5000.0 in Q4 2021.
• Historically, Cost of Revenue has averaged $1.2 million across 5 years, with a median of $974000.0 in 2018.
• The sharpest annual moves came in 2018 and 2021: Cost of Revenue advanced 26.24% in 2018, then sank 99.08% in 2021.
• Over 5 years, Cost of Revenue stood at $2.0 million in 2017, then slumped by 51.69% to $974000.0 in 2018, then tumbled by 35.22% to $631000.0 in 2019, then decreased by 13.95% to $543000.0 in 2020, then tumbled by 99.08% to $5000.0 in 2021.
• According to Business Quant data, Cost of Revenue over the past three periods registered $5000.0, $543000.0, and $515000.0 for Q4 2021, Q4 2020, and Q3 2020 respectively.